However, no case of new‐onset dipeptidyl peptidase 4 inhibitors‐associated BP (DPP‐4i‐BP) occurring after SARS‐CoV‐2 mRNA vaccination in patients with SLE has been reported. Here, DPP4 is linked to systemic lupus erythematosus.